AstraZeneca PLC (AZN) |
|
53.32 0.43 (0.81%)
|
07-01 16:00 |
|
Open: |
52.83 |
Pre. Close: |
52.89 |
|
High:
|
53.68 |
Low:
|
52.39 |
|
Volume:
|
5,353,415 |
Market Cap:
|
137,126M |
|
|
|
|
AstraZeneca PLC discovers, develops, and commercializes prescription medicines in the areas of oncology, cardiovascular, renal and metabolism, respiratory, autoimmunity, infection, neuroscience, and gastroenterology worldwide. Its marketed products include Arimidex, Casodex/Cosudex, Calquence, Faslodex, Imfinzi, Iressa, Lynparza, Nolvadex, Tagrisso, and Zoladex for oncology diseases; Atacand/Atacand HCT/Atacand Plus, Brilinta/Brilique, Crestor, Plendil, Seloken/Toprol-XL, Tenormin, and Zestril for cardiovascular diseases; and Bydureon, Byetta, Farxiga/Forxiga, Kombiglyze XR/Komboglyze, Onglyza, Qtern, Symlin, Xigduo/Xigduo XR for metabolic diseases. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
53.73 - 53.99 |
53.99 - 54.215 |
|
Low:
|
51.768 - 52.068 |
52.068 - 52.327 |
|
Close:
|
52.868 - 53.336 |
53.336 - 53.74 |
|
Technical analysis |
as of: 2020-07-01 4:30:21 PM |
|
Overall:
|
  |
| Stoxline posted a STRONG BUY today, upgraded from lower rating. Upward movement to be expected. |
| Target: |
Six months: 64.95 One year: 75.86 |
| Support: |
Support1: 52.73 Support2: 50.95 |
| Resistance: |
Resistance1: 55.61 Resistance2: 64.95 |
| Pivot: |
52.90  |
| Moving Average: |
MA(5): 52.97 MA(20): 53.01
MA(100): 49.29 MA(250): 47.38 |
| MACD: |
MACD(12,26): 0.04 Signal(9): 0.11 |
| Stochastic oscillator: |
%K(14,3): 49.29 %D(3): 46.36 |
| RSI: |
RSI(14): 51.78 |
| 52-week: |
High: 57.44 Low: 36.15 Change(%): 30.2 |
| Average Vol(K): |
3-Month: 498484 10-Days: 567903 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.AZN has closed below upper band by 35.8%. Bollinger Bands are 52.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to AZN's normal range. The bands have been in this narrow range for 6 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Headline News |
Wed, 01 Jul 2020
Which Companies Are Producing Potential Coronavirus Vaccines? - TheStreet
Wed, 01 Jul 2020
BMY or AZN: Which Is the Better Value Stock Right Now? - Yahoo Finance
Wed, 01 Jul 2020
FDA Issues Guidance for Coronavirus Vaccine Developers - Yahoo Finance
Wed, 01 Jul 2020
Is Now the Time to Buy AstraZeneca PLC (NYSE:AZN)? Analyst's Take - Pineville
Wed, 01 Jul 2020
BioSig Technologies Inc. Appoints Tony Zook to the Board of Directors - GlobeNewswire
Tue, 30 Jun 2020
Astrazeneca News Headlines. AZN Share News. Financial News Articles for Astrazeneca Plc Ord Shs $0.25 updated throughout the day. - London South East
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: New York Stock Exchange |
| Sector: Healthcare |
| Industry: Drug ManufacturersGeneral |
| Shares Out. (M) |
2,620 |
| Shares Float (M) |
2,620 |
|
% Held by Insiders
|
|
|
% Held by Institutions
|
18.47 |
|
Shares Short (K)
|
3,170 |
|
Shares Short P. Month (K)
|
3,560 |
Stock Financials |
|
EPS
|
0.580 |
|
EPS Est This Year
|
1.910 |
|
EPS Est Next Year
|
1.700 |
|
Book Value (p.s.)
|
4.110 |
|
Profit Margin
|
6.03 |
|
Operating Margin
|
13.48 |
|
Return on Assets (ttm)
|
3.6 |
|
Return on Equity (ttm)
|
11.7 |
|
Qtrly Rev. Growth
|
15.7 |
|
Gross Profit (p.s.)
|
7.458 |
|
Sales Per Share
|
9.637 |
|
EBITDA (p.s.)
|
2.279 |
|
Qtrly Earnings Growth
|
31.50 |
|
Operating Cash Flow (M)
|
3,500 |
|
Levered Free Cash Flow (M)
|
4,130 |
Stock Valuations |
|
PE Ratio
|
91.93 |
|
PEG Ratio
|
1.49 |
|
Price to Book value
|
12.97 |
|
Price to Sales
|
5.53 |
|
Price to Cash Flow
|
39.91 |
Stock Dividends |
|
Dividend
|
2.800 |
|
Forward Dividend
|
1.400 |
|
Dividend Yield
|
0.05 |
|
Dividend Pay Date
|
2020-03-29 |
|
Ex-Dividend Date
|
2020-02-26 |
|
7 Binary Options
|
|
Your Ad Here
|
|
